No black box warning on record for Methylergonovine Maleate

As of the latest FDA labeling reviewed, Methylergonovine Maleate (METHYLERGONOVINE MALEATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Methylergonovine Maleate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS General This drug should not be administered I.V. routinely because of the possibility of inducing sudden hypertensive and cerebrovascular accidents. If I.V administration is considered essential as a lifesaving measure, methylergonovine maleate should be given slowly over a period of no less than 60 seconds with careful monitoring of blood pressure. Intra-arterial or periarterial injecti

No black box warning on record for Methylergonovine Maleate

Other warnings & precautions

WARNINGS General This drug should not be administered I.V. routinely because of the possibility of inducing sudden hypertensive and cerebrovascular accidents. If I.V administration is considered essential as a lifesaving measure, methylergonovine maleate should be given slowly over a period of no less than 60 seconds with careful monitoring of blood pressure. Intra-arterial or periarterial injecti

Methylergonovine Maleate Black Box Warning

No black box warning on record for Methylergonovine Maleate

Other warnings & precautions

Methylergonovine Maleate Black Box Warning

No black box warning on record for Methylergonovine Maleate

Other warnings & precautions